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Highly polarized Th17 cells induce EAE via a T-bet
independent mechanism
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In theMOG35–55 induced EAEmodel, autoreactive Th17 cells that accumulate in the central
nervous system acquire Th1 characteristics via a T-bet dependent mechanism. It remains
to be determined whether Th17 plasticity and encephalitogenicity are causally related
to each other. Here, we show that IL-23 polarized T-bet−/− Th17 cells are unimpaired in
either activation or proliferation, and induce higher quantities of the chemokines RANTES
and CXCL2 than WT Th17 cells. Unlike their WT counterparts, T-bet−/− Th17 cells retain
an IL-17hiIFN-γneg-lo cytokine profile following adoptive transfer into syngeneic hosts.
This population of highly polarized Th17 effectors is capable of mediating EAE, albeit
with a milder clinical course. It has previously been reported that the signature Th1 and
Th17 effector cytokines, IFN-γ and IL-17, are dispensable for the development of autoim-
mune demyelinating disease. The current study demonstrates that the “master regulator”
transcription factor, T-bet, is also not universally required for encephalitogenicity. Our
results contribute to a growing body of data showing heterogeneity of myelin-reactive
T cells and the independent mechanisms they employ to inflict damage to central ner-
vous system tissues, complicating the search for therapeutic targets relevant across the
spectrum of individuals with multiple sclerosis.
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Introduction
EAE is a CD4+ T-cell-mediated autoimmune disease of the central
nervous system (CNS), widely used as an animal model of mul-
tiple sclerosis (MS). Despite substantial progress in elucidating
pathogenic pathways that drive EAE, the mechanisms employed
by autoreactive T cells to initiate inflammatory demyelination and,
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hence, the effector functions that are critical for their encephali-
togenicity, are largely unknown. We and others have previously
shown that IL-12-polarized Th1 and IL-23-polarized Th17 cells
specific for the same myelin antigen are independently capable
of inducing EAE following adoptive transfer into na¨ıve syngeneic
hosts [1,2]. Surprisingly, full blown disease occurs in the absence
of the signature Th1 and Th17 cytokines, IFN-γ, and IL-17A/F,
either alone or in combination [3–5]. More recently, the master
regulatory transcription factor, T-bet, was identified as a critical
molecule in the programming of encephalitogenic Th17 as well
as Th1 cells [6]. T-bet was originally described as a driver of
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Th1 differentiation via direct activation of the IFN-γ gene and
upregulation of the IL-12 receptor β2 chain [7, 8]. Gocke et al.
[9] subsequently reported that T-bet could also promote the dif-
ferentiation of autoimmune effector Th17 cells by inducing IL-23
receptor expression.
Several laboratories have established a role for T-bet in the
plasticity of Th17 cells, particularly in their acquisition of Th1-like
characteristics to become so called “ex-Th17” cells [10–12]. Fate
mapping experiments using IL-17 reporter mice demonstrated that
the majority of CD4+ T cells infiltrating the CNS of C57BL/6
mice actively immunized with a peptide of myelin oligodendrocyte
glycoprotein (MOG35–55) are ex-Th17 cells [13,14]. This observa-
tion has led some investigators to speculate that the plasticity of
myelin-reactive Th17 cells is causally related to their acquisition of
encephalitogenic properties. If they are correct then T-bet would
be critical for the development of EAE based on its role in facil-
itating the transition of myelin reactive Th17 cells into ex-Th17
cells. In the current study we directly assess the requirement of
T-bet expression in IL-23 polarized, myelin-reactive T cells for the
adoptive transfer of EAE. We find that, unlike their WT counter-
parts, autoreactive T-bet−/− cells resist conversion to an ex-Th17
phenotype upon in vitro or in vivo reactivation. Moreover, these
stable Th17 cells trigger the accumulation of myeloid cells in the
spleen and CNS, thereby retaining the ability to induce EAE in WT
as well as RAG2-deficient hosts.
Results
MOG35–55 immunized T-bet−/− mice generate a Th17
biased response and succumb to EAE
The master transcription factor, T-bet, has been implicated in
the pathogenesis of EAE and MS [15–18]. We revisited the role
of T-bet in EAE by comparing the clinical courses of C57BL/6
T-bet−/− andWTmice following subcutaneous immunization with
an emulsion of MOG35–55 in CFA and intraperitoneal injection of
inactivated Bordetella pertussis toxin. Ninety percent of T-bet−/−
mice succumbed to moderate to severe EAE, although disease
onset was slightly delayed compared with that of their WT coun-
terparts (Fig. 1A). Examination of cytokine expression by CNS
mononuclear cells pooled from representative mice in each group,
and by splenocytes harvested from individual mice at peak EAE,
revealed skewing toward an IL-17+IFN-γ− profile in the T-bet−/−
cohort (Fig. 1B and C). Splenocytes from immunized T-bet−/−
mice produced significantly higher levels of IL-17 and lower levels
of IFN-γ than splenocytes from WT mice in response to in vitro
challenge with MOG35–55 (Fig. 1D).
IL-23 polarized T-bet−/− Th17 cells are phenotypically
stable in vitro and in vivo
Collectively, these data suggested that in the absence of T-bet,
inflammatory demyelination was mediated by myelin-reactive
Th17 cells that resist conversion to ex-Th17 cells. In support of
this hypothesis, MOG-primed T-bet−/− CD4+ T cells predomi-
nantly exhibited an IL-17+IFN-γ− profile following a 96 h cul-
ture with antigen plus recombinant IL-23 and IL-1β, while a sig-
nificant percent of WT CD4+ T cells cultured under the same
conditions were IL-17−IFN-γ+ (Fig. 2A). IL-23 polarized T-bet−/−
CD4+ T cells maintained a Th17 phenotype upon secondary chal-
lenge with MOG35–55 alone (Fig. 2B and C). Multiplex bead
immunoassays revealed increased levels of RANTES and CXCL2 in
supernatants from primary cultures of T-bet−/− Th17 cells by com-
parison with WT Th17 cells (Fig. 2D). Conversely, the concentra-
tion of the IFN-γ-induced chemokine CXCL9 was relatively low
in supernatants from T-bet−/− Th17 cell cultures. T-bet−/− cells
also expressed GM-CSF at a lower frequency than WT cells during
primary culture (Fig. 2A). However, T-bet−/− and WT Th17 cells
secreted comparable quantities of GM-CSF upon secondary chal-
lenge (Supporting Information Fig. 1). T-bet−/− andWTTh17 cells
produced similar quantities of other cytokines and chemokines
implicated in EAE pathogenesis, including IL-1α, IL-6, and G-CSF
(Fig. 2D). The majority of T-bet−/− Th17 cells upregulated activa-
tion markers and proliferated in response to antigen to a similar
extent as their WT counterparts (Fig. 2E), indicating that their
failure to acquire Th1 characteristics was not a consequence of
insufficient antigen presentation or TCR engagement. The fact
that a relatively high percentage of T-bet−/− cells expressed a
CD44+CD69+CD25+CD62Lneg profile could reflect a less differen-
tiated state [19].
We next compared the stability of MOG-primed, IL-23 polar-
ized T-bet−/− and WT CD4+ CD45.2+ T cells in vivo following
transfer into na¨ıve CD45.1 congenic hosts. Spleens harvested from
the recipients of T-bet−/− donor cells contained a higher frequency
of MOG35–55-specific IL-17 producers and a lower frequency of
MOG35–55-specific IFN-γ producers than spleens from recipients of
WT donor cells (Fig. 3A). These stable T-bet−/− Th17 cells induced
EAE in 85–90% of hosts, although disease severity was reduced
compared with recipients of WT cells (Fig. 3B). IL-23 polarized
T-bet−/− Th17 cells did not express FoxP3 and did not mitigate
EAE severity when cotransferred with WT Th17 effectors (data
not shown).
FACS analysis of spinal cord mononuclear cells at peak disease
indicated that the majority of infiltrating CD45.2+ T-bet−/− donor
cells were IL-17+IFN-γ−, while themajority of infiltrating CD45.2+
WT donor cells were IL-17−IFN-γ+ (Fig. 3C).
T-bet−/− Th17 cells transfer EAE to hosts lacking
endogenous B or T lymphocytes
Although T-bet−/− donor cells were enriched for the CD4+
T-cell subset prior to transfer, we entertained the possibility that
immunocompetent host T cells had been activated by contaminat-
ing donor APCs bearing MOG35–55/class II complexes. Therefore,
we repeated the adoptive transfer experiments using RAG2−/−
recipients. Consistent with the results obtained in immunocompe-
tent hosts, RAG2−/− mice were susceptible to disease induced by
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Figure 1. MOG35–55 primed T-bet−/− mice mount an enhanced Th17 response and succumb to EAE. EAE was induced in WT and T-bet−/− C57BL/6
mice via immunizationwithMOG35–55 in CFA and administration of inactivated pertussis toxin. (A)WT (closed squares) and T-bet−/− (open squares)
mice were rated on a daily basis for degree of neurological disability by an examiner blinded to genotype. Clinical scores for each cohort were aver-
aged over two experimentswith a total of 8–10mice/group. (B) CNSmcells and (C) splenocyteswere harvested at peak EAE. PooledCNSmononuclear
cells, or splenocytes harvested from individual mice, were analyzed by intracellular staining and flow cytometry following stimulation with PMA
and ionomycin for 6 h. Representative flow cytometry plots are gated on CD4+ T cells. Each symbol in the right panel in (C) represents the percent
of cytokine positive cells among splenocytes from an individual mouse. Data shown are from one experiment representative of three independent
experiments performed. Bar represents mean. (D) Splenocytes obtained fromMOG35–55-immunizedWT (closed bars) and T-bet−/− (open bars) mice
were cultured with either MOG35–55 at the indicated concentrations, PMA and anti-CD3, or medium only. Supernatants were collected at 96 h and
subjected to sandwich ELISA to measure cytokine levels. The data are shown as mean +SEM of five mice per group and are from one experi-
ment representative of four experiments performed. *** p < 0.001; ** p < 0.01; * p < 0.05 compared to WT control, unpaired, two-tailed Student’s
t-test.
IL-23 polarized T-bet−/− donor cells (Fig. 3D). At peak disease, a
very high percent of the T-bet−/− cells that had accumulated in
the CNS of RAG2−/− recipients were IL-17+IFN-γ− (Fig. 3E and F,
left panel). Similarly, the frequency of IL-17+IFN-γ− T-bet−/− cells
was significantly higher than that of WT donor Th17 cells in the
spleen (Fig. 3F, right panel). IFN-γ single-producing T-bet−/− cells
were virtually undetectable either in the spleen or the CNS. In con-
trast, IL-17−IFN-γ+ cells were more numerous than IL-17+IFN-γ−
cells among the WT donor population in both the periphery and
the CNS. Spleens of RAG2−/− mice that received T-bet−/− donor
cells were disproportionately enlarged, primarily due to a local
expansion of myeloid cells (Fig. 3G, right panel). There was no
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difference in the absolute numbers of CD4+CD3+ T cells, granulo-
cytes or monocytes infiltrating the spinal cords of T-bet−/− or WT
hosts (Fig. 3G, left panel).
Discussion
MS is a heterogeneous disease characterized by diversity in both
the clinical course and in responsiveness to individual therapeu-
tic agents. At present, no biomarkers have been identified that
can guide the selection of an optimal disease modifying regimen.
Strategies to manage MS are complicated by the observation that
distinct myelin-reactive Th-cell subsets can induce inflammatory
demyelination via independent cellular and molecular pathways
[1]. Therefore it is not surprising that signature Th1 and Th17
cytokines are dispensable for the manifestation of EAE [3–5]. The
identification of a molecule that is critical for encephalitogenicity,
irrespective of Th effector phenotype, would serve as an ideal ther-
apeutic target. The transcription factor T-bet has been proposed as
a candidate therapeutic target in MS, based on its nonredundant
roles in Th1 differentiation and in Th17 plasticity. However, in the
current study we show that IL-23 polarized myelin-reactive Th17
cells can mediate autoimmune demyelination without expressing
T-bet or converting into Th1 (“ex-Th17”) cells. Consistent with
our findings, Duhen et al. [20] recently reported that T-bet defi-
ciency confined to CD4+ T cells does not confer resistance against
EAE induced by active immunization with MOG peptide emulsi-
fied in CFA. We found that stable T-bet−/− Th17 cells maintain the
capacity to produce GM-CSF, and induce augmented production
of CXCL2, each of which has been implicated in EAE pathogenesis
[21–24]. In ongoing studies we are investigating whether com-
pensatory upregulation of these factors drives the accumulation
of myeloid cells (Ly6G+ granulocytes in particular) in the spleens
of the recipients of T-bet−/− Th17 donor cells. Engagement of
alternative chemokine/cytokine pathways could underlie the pre-
served encephalitogenicity of myelin-reactive T-bet−/− Th17 cells.
We consistently found that MOG-specific T-bet−/− Th17 cells
induce a milder course of EAE than their WT counterparts. This
could be due to reduced production of the pro-inflammatory factor
GM-CSF, as we observed in primary cultures of T-bet−/− and WT
CD4+ T cells (Fig. 2A). However, we detected similar frequencies
of GM-CSF+ cells among T-bet−/− and WT donor cells harvested
from the CNS and peripheral lymphoid tissues of adoptive transfer
recipients with EAE (Fig. 3F and data not shown). Furthermore,
MOG-primed, Th17 polarized T-bet−/− andWT cells produce com-
parable amounts of GM-CSF upon secondary challenge (Supple-
mentary Information Fig. 1). The diminished potency of T-bet−/−
donor cells could also be secondary to a failure to express adhe-
sion molecules, such as P-selectin ligand, and chemokine recep-
tors, such as CXCR3, that facilitate efficient CNS trafficking [25].
The delay in clinical onset that we observed following adoptive
transfer of T-bet−/− effectors into RAG2−/− hosts (Fig. 3D) is con-
sistent with that hypothesis. Finally, our experiments revealed
differences in the composition of myeloid cells that were mobi-
lized and recruited by T-bet−/− versus WT effector cells (Fig. 3G
and data not shown) that could be responsible for differences in
EAE severity. Each of the above possibilities is currently under
investigation in our laboratory.
In conclusion, the current study contributes to a grow-
ing body of data that demonstrates that multiple parallel
immunopathogenic pathways can potentiate autoimmune neu-
roinflammation, and it suggests that disease-modifying therapies
might need to be customized based on immune profiling. 02
Materials and methods
Mice
Eight to 12-week-old C57BL/6 WT, CD45.1 congenic, T-bet−/−,
and RAG2−/− mice were obtained from the Jackson Laboratory
and housed in microisolator cages under specific pathogen-free
conditions. T-bet−/− and RAG2−/− mice were subsequently bred in
our facility. All animal protocols were approved by the University
Committee on Use and Care of Animals.
Induction of EAE
Mice were injected subcutaneously with 100 μg MOG35–55
(MEVGWYRSP-FSRVVHLYRNGK; Biosynthesis) in complete
Freund’s adjuvant (Difco). For induction of EAE by active immu-
nization, inactivated Bordetella pertussis toxin was administered
intraperitoneally on days 0 and 2.
 Figure 2. IL-23 polarized T-bet−/− Th17 cells are stable in vitro. WT and T-bet−/− mice were immunized with MOG35–55/CFA. Ten to 14 days later,
single cell suspensions of draining LN cells were cultured with MOG35–55 in the presence of IL-23, IL-1α, anti-IFN-γ, and anti-IL-4. (A) At 96 h cells
were harvested, washed, and stimulated with PMA and ionomycin for 6 h prior to for intracellular staining and flow cytometry. The percentages
of WT (black bars) and T-bet−/− (white bars) CD4+ T cells that expressed cytokines as indicated were averaged over seven experiments with 4–6
donors/group/experiment (left). Representative flow cytometry plots are gated on CD4+ T cells. (B) Following 96 h primary culture, LN cells were
washed and restimulatedwith T-cell-depleted syngeneic splenocytes pulsedwithMOG35–55. Supernatants collected 24 and 48 h later were analyzed
by ELISA. Data are shown as mean +SEM of three samples from three independent experiments. (C) LN cells from primed mice were cultured for
96 h in the presence of MOG35–55 and Th17 polarizing factors after which they were rested in the absence of antigen or recombinant cytokines
for an additional 96 h. They were then washed and restimulated with T-cell-depleted splenocytes and MOG35–55. Cells were harvested 24 h later
for intracellular staining followed by flow cytometry. Representative flow cytometry plots are gated on CD4+ T cells. (D) Supernatants from cells
cultured for 96 h as in (A) were analyzed by the Luminex protein assay. Data are shown as mean + SEM of two samples from two experiments.
(E) CFSE dilution (top) and activation status (bottom) of cells cultured as in (C). Cells were stained with CFSE prior to rechallenge with MOG35–55
(solid line) or media alone (shaded) and analyzed by flow cytometry 6 days later. Activationmarker expression was assessed 24 h after rechallenge.
Histograms are gated on CD4+ T cells. *** p < 0.001; ** p < 0.01; * p < 0.05 compared to WT controls, unpaired two-tailed Student’s t-test.
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For induction of EAE by adoptive transfer, draining lymph
nodes were harvested 10–14 days postimmunization, homoge-
nized, and passed through a 70μm cell strainer (BD Falcon). LNCs
were cultured in vitro with MOG35–55 (50 μg/mL) under condi-
tions favorable to the generation of Th17 cells (rmIL-23, 8 ng/mL;
rm IL-1α, 10 ng/mL; anti-IFN-γ (clone XMG1.2), 10 μg/mL; anti-
IL-4 (clone 11B11), 10 μg/mL). A total of 2 × 106 CD4+ T cells
were injected intraperitoneally, and mice were observed daily for
signs of EAE as described previously [24].
Flow cytometry
Spinal cords were harvested at peak disease, homogenized in
DNase (1 mg/mL) and collagenase A (2 mg/mL) and incu-
bated for 30 min at 37◦C. Mononuclear cells were isolated over
a 30/70% Percoll gradient (GE Healthcare). Splenocytes were
passed through a 70-μm cell strainer, ACK lysed and washed twice
prior to analysis. For intracellular staining, cells were stimulated
with PMA (50 ng/mL) and ionomycin (2 μg/mL) in the pres-
ence of brefeldin A (10 μg/mL) for 6 h or with MOG35–55 for
24 h. Cells were fixed with 4% paraformaldehyde and permeabi-
lized with 0.5% saponin prior to incubation with flourochrome-
conjugated antibodies. Flow cytometry was performed using a BD
FacsCanto II.
ELISA
Splenocytes were cultured with or without MOG35–55 (50 μg/mL)
in a 96well plate (2× 106 cells/well). Supernatants were collected
at serial time points and analyzed by sandwich ELISA according to
the manufacturer’s protocol (eBioscience). In some experiments,
cell culture supernatants were analyzed using luminex protein
array according to the manufacturer’s instructions (Millipore).
ELISPOT assay
The frequency of antigen-specific cytokine producers was deter-
mined following culture for 24 h in 96-well filtration plates
(Millipore), with or without 50 μg/mLMOG35–55. Antibodies from
eBioscience were: anti-IL-17 (TC11–18H10), biotinylated anti-
IL-17 (TC11–8H4), IFN-γ (AN18), and biotinylated anti-IFN-γ
(R4–6A2). Streptavidin–alkaline phosphatase (Southern Biotech)
and an alkaline phosphatase substrate kit (Vector Laboratories)
were used to identify trapped cytokine. Spots were counted
using the CTL ImmunoSpot Analyzer (Cellular Technology) with
ImmunoSpot software, and the number of spots in the medium-
only wells subtracted to generate the data shown.
Statistical analysis
Statistical analyses were performed using GraphPad Prism sta-
tistical analysis software. Group differences were analyzed by
unpaired, two-tailed Students t-test. p-values of 0.05 or less were
considered significant.
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